Call Options Transactions Made in Q3 2024 in Travere Therapeutics, Inc. (TVTX)
This table provides information about the institutional ownership of Travere Therapeutics, Inc. (TVTX) during Q3 2024. The information is specifically focused on institutions that hold call options of Travere Therapeutics, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Nov 14, 2024
Q3 2024
|
Sphera Funds Management Ltd.
Tel Aviv, L3 |
BUY
|
CALL |
171KNew |
$1.35M - $2.6M
|
171K
$3.98M
|
|
|
Nov 13, 2024
Q3 2024
|
Wells Fargo & Company
San Francisco, CA |
BUY
|
CALL |
168KNew |
$1.33M - $2.56M
|
168K
$3.92M
|
|
|
Nov 14, 2024
Q3 2024
|
Bank Of America Corp
Charlotte, NC |
BUY
|
CALL |
120KNew |
$947K - $1.83M
|
120K
$2.8M
|
|
|
Nov 14, 2024
Q3 2024
|
Jane Street Group, LLC
New York, NY |
BUY
|
CALL |
95.9KNew |
$757K - $1.46M
|
95.9K
$2.24M
|
|
|
Nov 14, 2024
Q3 2024
|
Caption Management, LLC
Oklahoma City, OK |
BUY
|
CALL |
84KNew |
$663K - $1.28M
|
84K
$1.96M
|
|
|
Nov 14, 2024
Q3 2024
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
BUY
|
CALL |
30.5K+ 100.0% |
$241K - $464K
|
61K
$1.42M
|
|
|
Nov 14, 2024
Q3 2024
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
SELL
|
CALL |
-8.5K- 9.96% |
$67.1K - $129K
|
76.8K
$1.79M
|